Therefore, angiotensin-converting enzyme inhibitors and AT1R antagonists, which target Ang II, are currently the first-line treatments for hypertension, especially in patients with hypertension complicated by diabetes or renal function failure (113, 114). This evidence concerns the gene ACE and hypertensive disorder.